Allakos Inc. (NASDAQ:ALLK – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 5,080,000 shares, a drop of 9.1% from the April 30th total of 5,590,000 shares. Based on an average daily volume of 528,900 shares, the days-to-cover ratio is […]
Premier Fund Managers Ltd trimmed its holdings in Evolent Health, Inc. (NYSE:EVH – Free Report) by 42.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 12,449 shares of the technology company’s stock after selling 9,326 shares during the period. Premier Fund Managers Ltd’s […]
Investment analysts at Cantor Fitzgerald began coverage on shares of ADC Therapeutics (NYSE:ADCT – Get Free Report) in a report released on Thursday, Marketbeat.com reports. The brokerage set an “overweight” rating on the stock. A number of other brokerages have also issued reports on ADCT. Guggenheim reissued a “buy” rating on shares of ADC Therapeutics […]
Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA – Get Free Report) have earned an average recommendation of “Hold” from the three analysts that are presently covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation. The average 1 year price target among brokers that have updated their coverage on the […]
Shares of Prime Medicine, Inc. (NYSE:PRME – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twelve analysts that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average 12-month price […]